Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GLTO Galecto Inc
- Stocks
- Healthcare
- NASDAQ: GLTO
Price (delayed)
$2.88
Market cap
$3.81M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$15.54
Enterprise value
-$8.07M
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Highlights
GLTO's EPS is up by 46% year-on-year and by 16% since the previous quarter
GLTO's net income is up by 40% year-on-year and by 14% since the previous quarter
The quick ratio has contracted by 35% from the previous quarter but it has grown by 22% YoY
GLTO's equity has dropped by 51% year-on-year and by 13% since the previous quarter
Key stats
What are the main financial stats of GLTO
Market
Valuations
Earnings
Shares outstanding
1.32M
Market cap
$3.81M
Enterprise value
-$8.07M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.28
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$19.12M
Net income
-$18.5M
EBIT
-$18.45M
EBITDA
-$18.36M
Free cash flow
-$15.13M
Per share
Balance sheet
Liquidity
EPS
-$15.54
EPS diluted
-$15.54
Free cash flow per share
-$11.44
Book value per share
$10.37
Revenue per share
$0
TBVPS
$11.62
Total assets
$15.37M
Total liabilities
$1.66M
Debt
$60,000
Equity
$13.71M
Working capital
$13.37M
Debt to equity
0
Current ratio
9.62
Quick ratio
7.7
Net debt/EBITDA
0.65
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-89%
Return on equity
-99.9%
Return on invested capital
-1,286.1%
Return on capital employed
-133.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GLTO stock price
How has the Galecto stock price performed over time
Intraday
-1.2%
1 week
4.92%
1 month
21.01%
1 year
-81.71%
YTD
-38.06%
QTD
-7.1%
Financial performance
How have Galecto's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.12M
Net income
-$18.5M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 41% YoY and by 14% QoQ
GLTO's net income is up by 40% year-on-year and by 14% since the previous quarter
Price vs fundamentals
How does GLTO's price correlate with its fundamentals
Growth
What is Galecto's growth rate over time
Valuation
What is Galecto stock price valuation
P/E
N/A
P/B
0.28
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLTO's EPS is up by 46% year-on-year and by 16% since the previous quarter
GLTO's price to book (P/B) is 65% less than its 5-year quarterly average of 0.8 and 44% less than its last 4 quarters average of 0.5
GLTO's equity has dropped by 51% year-on-year and by 13% since the previous quarter
Efficiency
How efficient is Galecto business performance
The company's return on invested capital has shrunk by 63% QoQ
The return on assets has declined by 30% year-on-year and by 4.1% since the previous quarter
Galecto's ROE has decreased by 15% YoY and by 3.1% from the previous quarter
Dividends
What is GLTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GLTO.
Financial health
How did Galecto financials performed over time
Galecto's total liabilities has plunged by 62% YoY but it has increased by 27% from the previous quarter
The total assets has plunged by 53% YoY and by 10% from the previous quarter
Galecto's debt is 100% less than its equity
GLTO's equity has dropped by 51% year-on-year and by 13% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.